Your browser doesn't support javascript.
loading
Nuevos factores de riesgo de hemorragia pulmonar que complican la biopsia pulmonar guiada por TC en técnica coaxial / Novel risk factors of pulmonary hemorrhage complicating CT-guided lung biopsy in coaxial technique
Schroeder, Christophe; Loebelenz, Laura I; Noeldge, Gerd; Kim, Soung Yung; Heverhagen, Johannes T; Brönnimann, Michael P.
  • Schroeder, Christophe; University Hospital of Bern. Institute for Diagnostic, Interventional, and Pediatric Radiology. Freiburgstrasse. CH
  • Loebelenz, Laura I; University Hospital of Bern. Institute for Diagnostic, Interventional, and Pediatric Radiology. Freiburgstrasse. CH
  • Noeldge, Gerd; University Hospital of Bern. Institute for Diagnostic, Interventional, and Pediatric Radiology. Freiburgstrasse. CH
  • Kim, Soung Yung; Department of Radiology and Nuclear Medicin. Schaff hausen. CH
  • Heverhagen, Johannes T; University Hospital of Bern. Institute for Diagnostic, Interventional, and Pediatric Radiology. Freiburgstrasse. CH
  • Brönnimann, Michael P; University Hospital of Bern. Institute for Diagnostic, Interventional, and Pediatric Radiology. Freiburgstrasse. CH
Prensa méd. argent ; 107(2): 97-104, 20210000. fig, tab
Article in English | LILACS, BINACIS | ID: biblio-1361373
RESUMEN

Objetivos:

Evaluar la frecuencia y gravedad de la hemorragia parenquimatosa pulmonar tras la biopsia pulmonar con aguja transtorácica coaxial, según factores de procedimiento, aún no descritos en la literatura. El objetivo de este estudio fue determinar si la elección de la tecnología de biopsia coaxial, el posicionamiento del paciente y la dignidad de la lesión son tres nuevas variables que influyen en el riesgo de hemorragia parenquimatosa tras biopsias coaxiales de pulmón.

Métodos:

Se revisaron retrospectivamente los registros de 117 pacientes que se sometieron a biopsias con aguja transtorácica del pulmón entre enero de 2018 y abril de 2020. El resultado primario fue la hemorragia pulmonar. Se ha utilizado un sistema de clasificación para clasificar la hemorragia parenquimatosa pulmonar Grado 0 - Grado 3. Se evaluaron tres variables novedosas relacionadas con el paciente, la técnica y la lesión como predictores de hemorragia pulmonar tecnología de biopsia coaxial, posición del paciente y dignidad de la lesión.

Resultados:

De los 117 pacientes, 18 (15,4%) pacientes con tecnología de biopsia coaxial de corte, versus 29 (24,8%) pacientes con tecnología coaxial de núcleo completo mostraron hemorragia significativa en las exploraciones de control posteriores a la biopsia. (IC del 95% 0,06-0,33, p <0,0001). No hubo diferencias significativas en la hemorragia pulmonar entre el diagnóstico histológico benigno y maligno (IC 95% 0,84-4,44, p = 0,1199) y la posición del paciente en decúbito prono o supino (IC 95% 0,57-2,57, p = 0,6232).

Conclusiones:

La incidencia y gravedad de la hemorragia pulmonar depende de la tecnología de biopsia coaxial utilizada; siendo mayor en pacientes sometidos a una biopsia con tecnología full-core y menor después del uso de tecnología de corte. En este estudio de pronóstico no se estableció una correlación significativa entre la hemorragia pulmonar parenquimatosa y la posición del paciente o la dignidad de la lesión
ABSTRACT

Objectives:

To evaluate the frequency and severity of pulmonary parenchymal hemorrhage after coaxial transthoracic needle biopsy of the lung, according to procedural factors, not yet described in literature. The aim of this study was to determine whether the choice of the coaxial biopsy technology, patient positioning and the lesion dignity are three new variables influencing the risk of parenchymal hemorrhage after coaxial biopsies of the lung.

Methods:

Records from 117 patients who underwent transthoracic needle biopsies of the lung between January 2018 and April 2020 have been retrospectively reviewed. The primary outcome was pulmonary hemorrhage. A grading system has been used to classify pulmonary parenchymal hemorrhage Grade 0 ­ Grade 3. Three novel patient, technique and lesion-related variables were evaluated as predictors of pulmonary hemorrhage coaxial biopsy technology, patient positioning and lesion dignity.

Results:

Out of the 117 patients, 18 (15,4%) patients with cutting coaxial biopsy technology, versus 29 (24,8%) patients with full core coaxial technology showed significant hemorrhage on the post-biopsy control scans. (95% CI 0,06-0,33, p<0,0001). No significant difference in pulmonary hemorrhage between benign and malignant histological diagnosis (95% CI 0,84-4,44, p=0,1199) and prone or supine patient positioning (95% CI 0,57-2,57, p= 0,6232) was found.

Conclusions:

The incidence and severity of pulmonary hemorrhage depends on the coaxial biopsy technology used; being higher in patients undergoing a biopsy with full-core technology and lower after the use of cutting technology. No significant correlation between parenchymal pulmonary hemorrhage and patient positioning or lesion dignity was established in this prognostic study.
Subject(s)

Full text: Available Index: LILACS (Americas) Main subject: Prognosis / Tomography, X-Ray Computed / Retrospective Studies / Risk Factors / Lung Injury / Image-Guided Biopsy / Hemorrhage Type of study: Etiology study / Observational study / Prognostic study / Risk factors Limits: Humans Language: English Journal: Prensa méd. argent Journal subject: Medicine Year: 2021 Type: Article Affiliation country: Switzerland Institution/Affiliation country: Department of Radiology and Nuclear Medicin/CH / University Hospital of Bern/CH

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: LILACS (Americas) Main subject: Prognosis / Tomography, X-Ray Computed / Retrospective Studies / Risk Factors / Lung Injury / Image-Guided Biopsy / Hemorrhage Type of study: Etiology study / Observational study / Prognostic study / Risk factors Limits: Humans Language: English Journal: Prensa méd. argent Journal subject: Medicine Year: 2021 Type: Article Affiliation country: Switzerland Institution/Affiliation country: Department of Radiology and Nuclear Medicin/CH / University Hospital of Bern/CH